JP2009514901A5 - - Google Patents

Download PDF

Info

Publication number
JP2009514901A5
JP2009514901A5 JP2008539185A JP2008539185A JP2009514901A5 JP 2009514901 A5 JP2009514901 A5 JP 2009514901A5 JP 2008539185 A JP2008539185 A JP 2008539185A JP 2008539185 A JP2008539185 A JP 2008539185A JP 2009514901 A5 JP2009514901 A5 JP 2009514901A5
Authority
JP
Japan
Prior art keywords
psidium
extract
pharmaceutical composition
composition according
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008539185A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009514901A (ja
JP5717317B2 (ja
Filing date
Publication date
Priority claimed from AT0183305A external-priority patent/AT502717A1/de
Application filed filed Critical
Publication of JP2009514901A publication Critical patent/JP2009514901A/ja
Publication of JP2009514901A5 publication Critical patent/JP2009514901A5/ja
Application granted granted Critical
Publication of JP5717317B2 publication Critical patent/JP5717317B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008539185A 2005-11-09 2006-11-08 化合物の医薬品的使用 Active JP5717317B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ATA1833/2005 2005-11-09
AT0183305A AT502717A1 (de) 2005-11-09 2005-11-09 Pharmazeutische verwendung einer verbindung
PCT/AT2006/000454 WO2007053865A1 (en) 2005-11-09 2006-11-08 Pharmaceutical use of a compound

Publications (3)

Publication Number Publication Date
JP2009514901A JP2009514901A (ja) 2009-04-09
JP2009514901A5 true JP2009514901A5 (cg-RX-API-DMAC7.html) 2012-12-27
JP5717317B2 JP5717317B2 (ja) 2015-05-13

Family

ID=37876593

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008539185A Active JP5717317B2 (ja) 2005-11-09 2006-11-08 化合物の医薬品的使用

Country Status (4)

Country Link
US (1) US20090186110A1 (cg-RX-API-DMAC7.html)
JP (1) JP5717317B2 (cg-RX-API-DMAC7.html)
AT (1) AT502717A1 (cg-RX-API-DMAC7.html)
WO (1) WO2007053865A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080293644A1 (en) * 2007-04-27 2008-11-27 Thomas Eidenberger Guava extract
JP2010105922A (ja) * 2008-10-28 2010-05-13 Uha Mikakuto Co Ltd Ｌｏｘ−１アンタゴニスト作用剤
CA2823534C (en) * 2010-12-28 2018-09-11 Mary Kay Inc. Topical composition comprising a psidium guajava extract and a kunzea ericoides extract for providing sebum control and treating acne
US8877259B2 (en) 2012-02-09 2014-11-04 Mary Kay Inc. Cosmetic formulation
CN103565928A (zh) * 2013-11-01 2014-02-12 华南农业大学 一种番石榴降糖活性组分、制备方法及用途
CN104173975A (zh) * 2014-08-25 2014-12-03 河南科技大学第一附属医院 一种用于治疗糖尿病的中药组合物
HK1249847A1 (zh) 2015-03-09 2018-11-16 Intekrin Therapeutics, Inc. 用於治疗非酒精性脂肪肝疾病和/或脂肪营养不良的方法
DE102016102265A1 (de) 2016-02-10 2017-08-10 Pm-International Ag Zusammensetzung zur Reduzierung und/oder Hemmung einer intestinalen Glucose-Resorption, Nahrungsergänzungsmittel, Verwendung der Zusammensetzung und Verfahren zur Herstellung des Nahrungsergänzungsmittels
WO2017137405A1 (de) 2016-02-10 2017-08-17 Pm-International Ag Zusammensetzung enthaltend guaijaverin zur reduzierung und/oder hemmung einer intestinalen glucose-resorption, nahrungsergänzungsmittel, verwendung der zusammensetzung und verfahren zur herstellung des nahrungsergänzungsmittels
DE102016102271A1 (de) 2016-02-10 2017-08-10 Pm-International Ag Zusammensetzung zur Reduzierung und/oder Hemmung einer intestinalen Glucose-Resorption, Nahrungsergänzungsmittel, Verwendung der Zusammensetzung und Verfahren zur Herstellung des Nahrungsergänzungsmittels
BR112019020485A2 (pt) 2017-04-03 2020-05-12 Coherus Biosciences, Inc. Agonista ppary para tratamento de paralisia supranuclear progressiva
WO2020025137A1 (de) * 2018-08-02 2020-02-06 Pm-International Ag Gänseblümchenextrakt

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4921475A (en) * 1983-08-18 1990-05-01 Drug Delivery Systems Inc. Transdermal drug patch with microtubes
US5087240A (en) * 1983-08-18 1992-02-11 Drug Delivery Systems Inc. Transdermal drug patch with conductive fibers
JPS6056923A (ja) * 1983-09-06 1985-04-02 Bizen Kasei Kk グアバ葉エキスの抽出方法
JPS6137731A (ja) * 1984-07-31 1986-02-22 Bizen Kasei Kk グアバ葉エキスを有効成分とする経口糖尿病薬
US5163899A (en) * 1987-03-20 1992-11-17 Drug Delivery Systems Inc. Transdermal drug delivery system
JPS63283563A (ja) * 1987-05-18 1988-11-21 Morishige Okinaga グァバ茶の製造方法
US5312325A (en) * 1987-05-28 1994-05-17 Drug Delivery Systems Inc Pulsating transdermal drug delivery system
GB8804164D0 (en) * 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US5008110A (en) * 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5088977A (en) * 1988-12-21 1992-02-18 Drug Delivery Systems Inc. Electrical transdermal drug applicator with counteractor and method of drug delivery
PT96059B (pt) * 1989-12-04 1998-07-31 Searle & Co Sistema de camada unica para a administracao de um medicamento por via transdermica
US5352456A (en) * 1991-10-10 1994-10-04 Cygnus Therapeutic Systems Device for administering drug transdermally which provides an initial pulse of drug
EP0553769B1 (de) * 1992-01-29 1996-01-03 FRANZ VÖLKL GmbH & CO. SKI UND TENNIS SPORTARTIKELFABRIK KG Ballspielschläger, insbesondere Tennisschläger
JP3193441B2 (ja) * 1992-03-09 2001-07-30 御木本製薬株式会社 美白化粧料
JP4109731B2 (ja) * 1997-01-23 2008-07-02 備前化成株式会社 改良グアバ葉エキス抽出法
EP1214308A2 (en) * 1999-09-23 2002-06-19 Vereniging Voor Christelijk Wetenschappelijk Onderwijs Novel flavonoids
ATE419036T1 (de) * 2000-03-31 2009-01-15 Prosidion Ltd Verbesserung der aktivität der inselzellen bei diabetes mellitus und dessen prävention
ES2173047B1 (es) * 2001-03-21 2004-01-01 Aplicaciones Farmacodinamicas Procedimiento para la obtencion de las diferentes fracciones de guayaba atomizada y su uso para el tratamiento de la diabetes mellitus tipo ii
KR100443264B1 (ko) * 2001-06-07 2004-08-04 한국생명공학연구원 구아바로부터 얻은 단백질 타이로신 탈인산화 효소 １ｂ 저해용 활성분획 추출물
WO2006074278A2 (en) * 2005-01-05 2006-07-13 Mitsunori Ono Compositions for treating diabetes or obesity

Similar Documents

Publication Publication Date Title
Kong et al. The genus Litsea in traditional Chinese medicine: an ethnomedical, phytochemical and pharmacological review
JP2009514901A5 (cg-RX-API-DMAC7.html)
CA2677872C (en) A composition for selective serotonin reuptake inhibition and process thereof
Lin et al. Research on a specialty mushroom (Pleurotus tuber-regium) as a functional food: chemical composition and biological activities
JP2008533131A5 (cg-RX-API-DMAC7.html)
Vasudevan et al. Memory-Enhancing Activity of Thespesia populnea. in Rats
KR101049041B1 (ko) 항염증 및 면역억제 효과를 갖는 여뀌 메탄올 추출물
US20110212194A1 (en) Composition for Inhibiting Melanogenesis and Use Thereof
US10960035B2 (en) Erodium crassifolium L'Her plant extracts and uses thereof
CN104274502B (zh) 一种圆齿野鸦椿高效抗炎作用化合物的提取方法、产品
JP2017119635A (ja) イグサ由来シクロオキシゲナーゼ−２阻害剤
JP2017206468A (ja) リソソーム活性促進剤
KR100963643B1 (ko) 손바닥선인장 열매의 종자 추출물 또는 이로부터 분리된화합물을 함유하는 간독성 질환 예방 및 치료용 조성물
Rene et al. Antimicrobial and antidiarrheal effects of four Cameroon medicinal plants: Dichrocephala integrifolia, Dioscorea preusii, Melenis minutiflora, and Tricalysia okelensis
Tanveer et al. Evaluation of anti-inflammatory and analgesic potential of aqueous methanolic extract of Thuja orientalis in albino rats.
Olukunle et al. Anti-inflammatory and analgesic potential of aqueous leaf extract of Tithonia diversifolia in rodents
FR2931664A1 (fr) Compositions a base de plantes et utilisations
KR101620153B1 (ko) 갯방풍 추출물을 유효성분으로 포함하는 관절염 예방 또는 치료용 조성물
WO2007070355A3 (en) Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
Gorain et al. Mechanistic description of natural herbs in the treatment of dementia: a systematic review
JP2006516542A5 (cg-RX-API-DMAC7.html)
Abdullahi et al. Analgesic, antiinflammatory and anti-pyretic activities of Tapinanthus dodoneifolius (DC) Danser extract using several experimental models in rodents
Poornima et al. Toxicological evaluation of ethanolic extract of Tabernaemontana coronaria (L) R. Br.
JP7349362B2 (ja) 化合物、化合物の製造法、富化抽出物、富化抽出物の活性な分画、富化抽出物の製造法、富化抽出物を製造するため植物バイオマスを選択する方法、免疫障害を治療するための組成物とその利用
JP2006036787A (ja) キサンチンオキシダーゼ阻害剤